The potential benefits and harms of screening for colorectal cancer

Keyphrases

• Australia 100%
• Confidence Interval 100%
• Potential Gains 100%
• Mortality Data 100%
• Potential Harm 100%
• Screening for Colorectal Cancer 100%
• Screening Test 50%
• Screening Program 50%
• Cost-effectiveness 50%
• Australian Guidelines 50%
• Australian Health System 50%
• Fecal Occult Blood Test 50%
• Colorectal Cancer Screening 50%
• Hemoccult 50%
• Metaanalysis 50%
• Annual Screening 50%
• Over 80 50%
• Over 40 50%
• Population Quality 50%
• Colorectal Cancer Mortality 50%
• Quality Control 50%
• Recall Mechanism 50%
• Informed Patient 50%
• Active Participation 50%
• Invasive Investigations 50%
• Public Health Association 50%
• Screening Trials 50%
• Interval Decisions 50%
• Australian Public 50%
• Healthcare Practitioners 50%
• Trial Results 50%

Medicine and Dentistry

• Health Care Cost 100%
• Colorectal Carcinoma 100%
• Meta-Analysis 50%
• Public Health 50%
• Screening Test 50%
• Health System 50%
• Screening Program 50%
• Cancer Mortality 50%
• N [bis(1 Aziridinyl)phosphinyl] 4 Iodobenzamide 50%
• Colorectal Cancer Screening 50%

Nursing and Health Professions

• Colorectal Carcinoma 100%
• Confidence Interval 66%
• Occult Blood 66%
• Meta Analysis 33%
• Public Health 33%
• Practice Guideline 33%
• Health Practitioner 33%
• Screening Test 33%
• Cancer Screening 33%
• Cancer Mortality 33%
• Quality Control 33%
• N [bis(1 Aziridinyl)phosphinyl] 4 Iodobenzamide 33%